Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R French

Showing results (481-490 of 506) with videos related to

Pageof 51
Sort By:
The Journal of Clinical Investigation|September 25, 2014
Mutation of FOXC1 and PITX2 induces cerebral small-vessel diseaseCurtis R French, Sudha Seshadri, Anita L Destefano, et al.
Communications Biology|June 24, 2021
TNF receptor agonists induce distinct receptor clusters to mediate differential agonistic activityXiaojie Yu, Sonya James, James H Felce, et al.
Cancer Cell|March 27, 2018
Complex Interplay between Epitope Specificity and Isotype Dictates the Biological Activity of Anti-human CD40 AntibodiesXiaojie Yu, H T Claude Chan, Christian M Orr, et al.
British Journal of Haematology|April 28, 2017
Effector mechanisms of IgA antibodies against CD20 include recruitment of myeloid cells for antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicityStefan Lohse, Sebastian Loew, Anna Kretschmer, et al.
Blood|March 13, 2010
Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selectionStephen A Beers, Ruth R French, H T Claude Chan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2006
The biological activity of human CD20 monoclonal antibodies is linked to unique epitopes on CD20Jessica L Teeling, Wendy J M Mackus, Luus J J M Wiegman, et al.
Blood|July 20, 2011
Fc gamma receptor IIb on target B cells promotes rituximab internalization and reduces clinical efficacySean H Lim, Andrew T Vaughan, Margaret Ashton-Key, et al.
The Journal of Allergy and Clinical Immunology|September 15, 2023
Human PLCG2 haploinsufficiency results in a novel natural killer cell immunodeficiencyJoshua B Alinger, Emily M Mace, Justin R Porter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 16, 2014
Fcγ receptor dependency of agonistic CD40 antibody in lymphoma therapy can be overcome through antibody multimerizationAnn L White, Lang Dou, H T Claude Chan, et al.
Cancer Cell|December 16, 2014
Conformation of the human immunoglobulin G2 hinge imparts superagonistic properties to immunostimulatory anticancer antibodiesAnn L White, H T Claude Chan, Ruth R French, et al.
Pageof 51

Showing results (481-490 of 506) with videos related to

Sort By:
Pageof 51
The Journal of Clinical Investigation|September 25, 2014
Mutation of FOXC1 and PITX2 induces cerebral small-vessel diseaseCurtis R French, Sudha Seshadri, Anita L Destefano, et al.
Communications Biology|June 24, 2021
TNF receptor agonists induce distinct receptor clusters to mediate differential agonistic activityXiaojie Yu, Sonya James, James H Felce, et al.
Cancer Cell|March 27, 2018
Complex Interplay between Epitope Specificity and Isotype Dictates the Biological Activity of Anti-human CD40 AntibodiesXiaojie Yu, H T Claude Chan, Christian M Orr, et al.
British Journal of Haematology|April 28, 2017
Effector mechanisms of IgA antibodies against CD20 include recruitment of myeloid cells for antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicityStefan Lohse, Sebastian Loew, Anna Kretschmer, et al.
Blood|March 13, 2010
Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selectionStephen A Beers, Ruth R French, H T Claude Chan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2006
The biological activity of human CD20 monoclonal antibodies is linked to unique epitopes on CD20Jessica L Teeling, Wendy J M Mackus, Luus J J M Wiegman, et al.
Blood|July 20, 2011
Fc gamma receptor IIb on target B cells promotes rituximab internalization and reduces clinical efficacySean H Lim, Andrew T Vaughan, Margaret Ashton-Key, et al.
The Journal of Allergy and Clinical Immunology|September 15, 2023
Human PLCG2 haploinsufficiency results in a novel natural killer cell immunodeficiencyJoshua B Alinger, Emily M Mace, Justin R Porter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 16, 2014
Fcγ receptor dependency of agonistic CD40 antibody in lymphoma therapy can be overcome through antibody multimerizationAnn L White, Lang Dou, H T Claude Chan, et al.
Cancer Cell|December 16, 2014
Conformation of the human immunoglobulin G2 hinge imparts superagonistic properties to immunostimulatory anticancer antibodiesAnn L White, H T Claude Chan, Ruth R French, et al.
Pageof 51